European Companies Search Engine
Managing Director (1) · Change of headquarters: Paul Wesjohann Beteiligungs-GmbH · Address · Capital: €26,000 · Shareholder agreement · Proxy policy · Corporate Purpose Hrb 3 Feb 2010 German Trade Register Announcements, Germany (01/02/2010)
Overview
Text
Vaxxinova GmbH,
Cuxhaven, Anton-Flettner-Str. 6, 27472 Cuxhaven
. GmbH. The shareholders' meeting of January 18, 2010 decided to amend the partnership agreement in Section 1 and with it the change of name (previously Paul Wesjohann Beteiligungs-GmbH) and the transfer of the registered office of Rechterfeld (previously Amtsgericht Oldenburg HRB 110475) to Cuxhaven. It was also decided to convert the share capital (DEM 50,000.00) to Eur, increase it from EUR 25,564.59 by EUR 435.41 to EUR 26,000.00 and amend the partnership agreement to Section 3 (share capital). In addition, S. 2 (object of the company), Section 7 (shareholder decisions), section 9 (assignment and division) and section 12 (notice) were amended. Business address:
Anton-Flettner-Str. 6, 27472 Cuxhaven
. Subject: Research, development, manufacture, technical service, marketing and distribution of veterinary products & services, in particular vaccines. Share capital: EUR 26,000.00. General representation scheme: If only one managing director is appointed, he shall represent the company alone. If several directors are appointed, the company is represented by two directors or by a managing director together with an authorized representative. Appointed as Managing Director: ?????????, ?????, Visbek-Rechterfeld, *??.??.????, authorized to represent one another; with the power to enter into legal transactions on behalf of the company in its own name or a.s. a representative of a third party.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Vaxxinova Autogenous Vaccines GmbH, Cuxhaven, Germany.